Breast Cancer A Challenging Problem

This volume summarizes the proceedings of the fifth biennial Cancer Teaching Symposium held on March 4 and 5, 1972 at the University of Chicago Pritzker School of Medicine. The program was prepared by Drs. MELVIN GRIEM, ELWOOD JENSEN, HAROLD SUTTON, JOHN ULTMANN, and ROBERT WISSLER. The purpose of t...

Full description

Bibliographic Details
Other Authors: Griem, M. S. (Editor), Jensen, E. V. (Editor), Ultmann, J. E. (Editor), Wissler, R. W. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1973, 1973
Edition:1st ed. 1973
Series:Recent Results in Cancer Research
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03670nmm a2200325 u 4500
001 EB000677583
003 EBX01000000000000000530665
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9783642858321 
100 1 |a Griem, M. S.  |e [editor] 
245 0 0 |a Breast Cancer  |h Elektronische Ressource  |b A Challenging Problem  |c edited by M. S. Griem, E. V. Jensen, J. E. Ultmann, R. W. Wissler 
250 |a 1st ed. 1973 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 1973, 1973 
300 |a XI, 152 p. 57 illus  |b online resource 
505 0 |a Opening of the Symposium -- The Challenge of Cancer of the Breast -- Session I -- Epidemiology of Breast Cancer -- Viral Transmission in Breast Cancer -- Hormonal Induction of Breast Cancer -- Appearance and Spread of Human Breast Cancer -- Session II -- Early Detection of Breast Cancer: X-Ray, Ultrasound, Thermography -- Recent Contributions to Our Knowledge about the Pathology of Breast Cancer -- Hormonal Dependency of Breast Cancer -- Is there Evidence that Immunity Influences Tumor-Horst Balance in Breast Cancer? -- Cell Kinetics of Breast Cancer: The Turnover of Nonproliferating Cells -- Session III -- Breast Cancer Survival Over Three Decades -- What is the Best Approach to the Primary Lesion in Breast Cancer? -- Surgical Therapy for Primary Mammary Cancer -- Is Prophylactic Use of Hormonal Therapy or Cytostatic Chemotherapy Beneficial in the Outcome of Breast Cancer? -- The Role of Hormone Therapy in the Management of Metastatic Breast Cancer -- What Chemotherapy Should be Used in Metastatic Breast Cancer? -- Epilogue 
653 |a Gynecology 
653 |a Gynecology  
653 |a Oncology 
700 1 |a Jensen, E. V.  |e [editor] 
700 1 |a Ultmann, J. E.  |e [editor] 
700 1 |a Wissler, R. W.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
490 0 |a Recent Results in Cancer Research 
028 5 0 |a 10.1007/978-3-642-85832-1 
856 4 0 |u https://doi.org/10.1007/978-3-642-85832-1?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
520 |a This volume summarizes the proceedings of the fifth biennial Cancer Teaching Symposium held on March 4 and 5, 1972 at the University of Chicago Pritzker School of Medicine. The program was prepared by Drs. MELVIN GRIEM, ELWOOD JENSEN, HAROLD SUTTON, JOHN ULTMANN, and ROBERT WISSLER. The purpose of the symposium was to present the current status of the challenging cancer problem, breast carcinoma, to the staff and students of this medical center and to students and in­ terested physicians from other institutions in the Chicago area. In a fashion similar to the other teaching symposia held in 1964, 1966, 1968,. and 1970, this symposium attracted over 450 physicians and scientists. In the course of one and one half days the audience had the opportunity to listen to 18 invited speakers and to the lively discussions. The formal presentations are recorded in these pages. This teaching symposium could not have been undertaken without the faithful assistance of the program committee, the cancer training grant education committee, the staff who recorded and transcribed the proceedings, and the editorial assistants. We wish to thank the following for their efforts: JULIE KANT, Administrative Secre­ tary for the Clinical Cancer Training Grant, as well as Dr. JAMES MARKS, MARGARET WOEHRLE, FRIEDA RANNEY, and ROSIE BARTLETT. This symposium received financial support from USPHS Clinical Cancer Train­ ing Grant 5T12 CA-08077-06 and from the Chicago Tumor Institute. MELVIN L. GRIEM, M. D. ROBERT W. WISSLER, Ph. D. , M. D.